VYNE

VYNE Therapeutics (VYNE)

VYNE Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VYNE

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/10	05 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VYNE	VYNE Therapeutics Inc
2024/05/09	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VYNE	VYNE Therapeutics Inc
2024/03/02	07 : 16	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:VYNE	VYNE Therapeutics Inc
2024/03/02	07 : 15	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:VYNE	VYNE Therapeutics Inc
2024/02/29	22 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VYNE	VYNE Therapeutics Inc
2024/02/02	23 : 42	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:VYNE	VYNE Therapeutics Inc
2024/01/04	07 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VYNE	VYNE Therapeutics Inc
2024/01/04	07 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VYNE	VYNE Therapeutics Inc
2024/01/04	07 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VYNE	VYNE Therapeutics Inc
2024/01/04	07 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VYNE	VYNE Therapeutics Inc
2024/01/04	07 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VYNE	VYNE Therapeutics Inc
2024/01/04	07 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VYNE	VYNE Therapeutics Inc
2024/01/04	07 : 01	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:VYNE	VYNE Therapeutics Inc
2024/01/03	22 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VYNE	VYNE Therapeutics Inc
2023/12/16	07 : 11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VYNE	VYNE Therapeutics Inc
2023/12/16	07 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VYNE	VYNE Therapeutics Inc
2023/12/16	07 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VYNE	VYNE Therapeutics Inc
2023/12/16	07 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VYNE	VYNE Therapeutics Inc
2023/12/16	07 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VYNE	VYNE Therapeutics Inc
2023/12/14	06 : 36	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:VYNE	VYNE Therapeutics Inc
2023/12/14	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VYNE	VYNE Therapeutics Inc
2023/12/05	06 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VYNE	VYNE Therapeutics Inc
2023/11/24	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:VYNE	VYNE Therapeutics Inc
2023/11/23	06 : 07	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VYNE	VYNE Therapeutics Inc
2023/11/17	06 : 30	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:VYNE	VYNE Therapeutics Inc
2023/11/14	06 : 30	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:VYNE	VYNE Therapeutics Inc
2023/11/14	06 : 03	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:VYNE	VYNE Therapeutics Inc
2023/11/14	06 : 01	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:VYNE	VYNE Therapeutics Inc
2023/11/14	05 : 59	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:VYNE	VYNE Therapeutics Inc
2023/11/13	21 : 57	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VYNE	VYNE Therapeutics Inc